NeoChord lands CE Mark for its mitral valve repair system

January 4, 2013 by MassDevice staff

Minnesota-based medical device maker NeoChord  receives CE Mark approval to market its DS1000 Mitral Valve Repair Device in European Union.

NeoChord logo

Minnesota device maker NeoChord won CE Mark approval in the European Union for its DS1000 Mitral Valve Repair system, the company announced this week.

The device allows the implantation of artificial chordae tendinae, thread-like tissues that anchor the leaflets of the mitral valve to heart muscle. Surgeons can use the device to repair mitral valve prolapse via a transapical, off-pump procedure, according to the company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp